Swedbank Robur Healthcare
- Namn
- Swedbank Robur Healthcare
- Fondbolag
- Swedbank Robur Fonder AB
- ISIN
- SE0000639445
- Kvartalsslut
- Fondförmögenhet
- 18 805 958 159 SEK
- Likvida medel
- 862 772 165 SEK
- Övriga tillgångar och skulder
- 42 224 801 SEK
- Antal innehav
- 56
- Aktiv risk
- 3,58
- Standardavvikelse 24 månader
- 11,00
- Jämförelseindex
- MSCI World Health Care 10/40 Net
-
Förvaltningsavgift
Healthcare A - 1,25% Fast
-
Förvaltningsavgift
Healthcare C - 1,25% Fast
Största innehav
| Namn | Marknadsvärde | Andel av fondförmögenhet | Bransch |
|---|---|---|---|
| United Health | 1 301 620 501 SEK | 6,92% | Health Care |
| AstraZeneca | 1 273 754 776 SEK | 6,77% | Health Care |
| Eli Lilly | 1 249 375 985 SEK | 6,64% | Health Care |
| Merck | 940 593 895 SEK | 5,00% | Health Care |
| Thermo Fisher Scientific | 867 144 035 SEK | 4,61% | Health Care |
| AbbVie | 855 904 443 SEK | 4,55% | Health Care |
| Novo Nordisk | 844 640 968 SEK | 4,49% | Health Care |
| Abbott Laboratories | 828 927 277 SEK | 4,41% | Health Care |
| Roche | 752 881 456 SEK | 4,00% | Health Care |
| Sanofi | 741 272 391 SEK | 3,94% | Health Care |
| McKesson | 689 730 350 SEK | 3,67% | Health Care |
| Boston Scientific | 684 554 612 SEK | 3,64% | Health Care |
| Centene | 655 580 809 SEK | 3,49% | Health Care |
| Vertex Pharmaceuticals | 639 527 055 SEK | 3,40% | Health Care |
| Danaher | 631 258 740 SEK | 3,36% | Health Care |
| Edward Lifesciences | 427 196 610 SEK | 2,27% | Health Care |
| Cooper Companies | 382 507 017 SEK | 2,03% | Health Care |
| Takeda | 327 877 277 SEK | 1,74% | Health Care |
| Becton Dickinson | 310 977 869 SEK | 1,65% | Health Care |
| Royalty Pharma | 280 964 587 SEK | 1,49% | Health Care |
| IQVIA | 269 843 616 SEK | 1,43% | Health Care |
| Hologic | 250 378 568 SEK | 1,33% | Health Care |
| Amgen | 185 787 405 SEK | 0,99% | Health Care |
| Sartorius | 172 954 190 SEK | 0,92% | Health Care |
| BioArctic | 170 878 400 SEK | 0,91% | Health Care |
Branscher
Källa: Finansinspektionen.